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SIVmac239 and SIVmac1A11 are wild-type viruses encoding Env proteins with full-length or truncated cytoplasmic tails (CTs),
respectively. A mutant designated SIVmac239T has a site-specific mutation which introduces a stop codon in the env gene resulting a
truncated protein of similar length to SIVmac1A11 Env. To investigate the role of specific sequence differences in these Env proteins, we
constructed SIV mutants encoding 1A11 or 239 Env proteins with reciprocal exchanges of the CT or exchanges of both the surface unit (SU)
and CT sequences. A truncated CT in the context of the 1A11 SU subunit was found to significantly enhance replication in CEMx174 (human
T-cell line) and rhesus PBMCs. However, similar Env CT truncation did not enhance replication of SIVmac239 in human or monkey cells.
SIVmac1A11 with a full-length SIVmac239 CT did not replicate in human T-cell lines, but truncation of the CT by a stop codon resulted in
replication. We also observed that these viruses differed significantly in sensitivity to neutralization by antibody. Taken together, the results
indicated that the length of the CT domain as well as specific sequence differences in the SU domain affect viral replication capacity as well
as sensitivity to neutralization.
D 2004 Elsevier Inc. All rights reserved.
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SIV and HIV isolates exhibit differences in sensitivity to
neutralization by antibody. Primary HIV-1 isolates are
generally observed to be more resistant to antibody-mediated
neutralization than T-cell-line-adapted isolates (Joag et al.,
1997). There is also a correlation between decreased depend-
ence on CD4 and increased sensitivity to antibody-mediated
neutralization (Means et al., 1997). Several studies have also
reported that changes in HIVor SIV neutralization sensitivity
result from passage in cell culture (Sawyer et al., 1994;
Vzorov and Compans, 2000; Wrin et al., 1995). SIVmac239
virus encodes a TM protein with a long CT domain of 164AA0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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E-mail address: compans@microbio.emory.edu (R.W. Compans).(Regier and Desrosiers, 1990). In contrast, SIVmac1A11, a
closely related strain, encodes a TM protein with a truncated
CT domain (Luciw et al., 1992). Continued passage of
SIVmac239 in HUT78 cells results in the appearance of a
virus encoding a TM protein with a truncated CT domain like
that of SIVmac1A11 (Kodama et al., 1989). In general, SIV
viruses with truncated Env proteins are CD4-independent,
neutralization-sensitive, and establish transient infection in
primates (Marthas et al., 1989; Puffer et al., 2002). During
passage of HIV-1 in cell culture, structural changes also occur
in the envelope glycoproteins that are associated with the
acquisition of a more neutralization-sensitive phenotype
(Parren et al., 1999).
Truncation of the SIV TM protein has multiple effects,
including increased incorporation of Env proteins into
virions or virus-like particles (VLPs) (Johnston et al.,
1993; Vzorov and Compans, 1996; Zingler and Littman,005) 89–101
Fig. 1. SIV envelope glycoprotein constructs used in this study. (Top) SIVmac239 envelope glycoprotein. The SU and TM reading frame is designated by a
box, and the membrane-spanning region is indicated by a vertical shaded box. Also indicated are the variable V1, V2, V3, V4, V5 regions and the location of
SphI, ClaI, NheI, BglII restriction sites. The positions of single or multiple amino acid residues that differ between the SIVmac239, SIVmac1A11 and cell
culture-adapted mutant SIVmac239 14T are indicated by a vertical line or black box. A site-specific C to T mutation present in the 239T env or SIVmac1A11
env gene changes a CAG glutamine codon at position 734 to a TAG termination codon shown by the black arrow. The cleavage site between the SU and TM
subunits is shown by the white arrow; gray bars indicate SIVmac239 Env protein sequences; striped bars indicate the SIVmac1A11 Env protein.
A.N. Vzorov et al. / Virology 332 (2005) 89–101901993), enhanced fusion activity of the Env protein (Ritter et
al., 1993; Spies and Compans, 1994), and alteration of the
conformation of the external domain (Spies et al., 1994;
Vzorov and Compans, 2000).
In the present study, we have investigated the effects of
specific sequence changes in the SIV Env protein CT and SU
domains on sensitivity of the virus to antibody neutraliza-
tion, as well as the replicative capacity of the virus.Fig. 2. The occurrence of specific amino acid mutations in cell culture-passaged S
2 months were analyzed using the DNA proviral cloning method. Vertical ma
observed at the corresponding positions in the sequence of SIVmac239 (Gene ba
viruses: one with 4 amino acid substitutions G201S, A239T, D294N, D374N desig
18T.Results
Construction of SIV with chimeric or mutant Env
Two closely related viruses SIVmac239 and SIV-
mac1A11 exhibit major differences in sensitivity to neu-
tralizing antibodies: SIVmac1A11 is neutralization-sensitive
and SIVmac239 is relatively resistant. To determine theIVmac239. The sequences of viral clones obtained from HUT78 cells over
rks and numbers with letters (in the left margin) indicate the mutations
nk # M33262). Two variants of cloned DNAwere used to obtained mutant
nated 14T and the second only with a single substitution A239T designated
Fig. 3. Replication of chimeric and mutant viruses in different cell lines.
The supernatants from transfected 239T cells collected after 72 h and
normalized for input virus by p27 content were used to infect HUT78,
CEMx174, or PBMCs as described in Materials and methods, and viral
replication was assayed by monitoring the expression of p27 capsid protein
in the supernatant. Panels show standard deviations (n = 3).
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protein on replication and neutralization of SIV, chimeric
viruses were constructed from molecular clones of SIV-
mac239 and SIVmac1A11 (Fig. 1). SIVmac2391A11CT and
SIVmac1A11239CT have reciprocal exchanges of the CT,
SIVmac1A11239Env has the SU and CT of Env SIV-
mac239 and the remainder of the TM sequence of 1A11.
SIVmac239T has a site-specific mutation in the env gene
which introduced a stop codon producing a truncated Env
protein.
Analysis of the sequences of SIVmac239 passaged in
HUT78 cells over 2 months showed that about 80% of
viral clones expressed a truncated Env protein. In addition,
however, other mutations were observed in the SU
subunits of all clones of the passaged virus, which were
mostly located between the V2 and V3 loops (Fig. 2). To
determine if these amino acid substitutions were important
in enhancement of the replication or neutralization
sensitivity of in T-cells, we constructed mutant viruses:
two with full-length Env proteins, with either 4 amino
acid substitutions G201S, A239T, D294N, D374N as
found in the clone or with a single substitution A239T;
and two with truncated Env proteins, with the same
mutations (Fig. 2).
Replication of SIV in human and monkey T-cells
After infection of HUT78, CEMx174 cells or rhesus
monkey PBMCs with similar amounts of input virus as
described in Materials and Methods, the kinetics of virus
replication and the level of viral production were analyzed
by measurement of the amount of viral p27 released into
culture medium for 7 days postinfection. SIVmac1A11
demonstrated the highest level of replication in CEMx174
cells, which was 7-fold higher than SIVmac2391A11CT and
29-fold higher than SIVmac239. Similarly in PBMCs, the
replication level of SIVmac1A11 was 5-fold higher than that
of SIVmac2391A11CT and 8-fold higher than SIVmac239
(Fig. 3). The levels of replication of SIVmac1A11 and
SIVmac2391A11CT were about the same in HUT78 cells,
and were 11-fold higher than SIVmac239. Cell culture-
adapted mutants of SIVmac239 (see above) designated
SIVmac239 18T with a single mutation A239T, or SIV-
mac239 14T with the mutations G201S, A239T, D294N,
D374N in the SU subunit (Fig. 2) and a truncated CT were
recovered after adaptation to HUT 78 cells. However, when a
full-length CT was reintroduced, the resulting viruses
replicated significantly lower than the parental virus SIV-
mac239: SIVmac239 18T, about 8-fold lower; and SIV-
mac239 14T, about 3-fold lower in HUT78 cells. These
viruses replicated to about the same level as SIV239-
mac1A11CTand SIVmac239 in CEMx174 cells and PBMCs
(not shown).
These results show that Env truncation in the context
of SIVmac1A11, 14T and 18T SU resulted in enhanced
replication during growth in human T cells.Expression of SIV proteins
In parallel to kinetic studies of replication, we also
compared viral protein expression by RIP and surface
biotinylation assays in CEMx174 cells and rhesus monkey
Fig. 4. Analysis of protein expression in SIV-infected cells. Rhesus monkey PBMCs (A, B) or CEMx174 cells (C) were infected by virus stocks collected after
21 days post infection of corresponding cells. After 1 week, infected cells were labeled with [35S] cysteine/methionine for 4 h. At the end of the labeling period,
the cell surface proteins were biotinylated and lysed, immunoprecipitated, and precipitated with streptavidin-agarose beads as described in Materials and
methods (B) or only lysed (A, C). SIV-specific proteins were immunoprecipitated with monoclonal anti-gp41 antibodies (A, C) or with a polyclonal anti-
SIVmac251 antiserum (B). For controls we used uninfected cells.
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two SIV viruses with lower IU/p27 ratios: SIVma-
c1A11239CT and SIVmac1A11239Env. After 28 days
post-infection in CEMx174 cells, we found that SIV viruses
with truncated Env proteins (SIVmac1A11, SIVma-
c2391A11CT and SIVmac239T) had similar high levels of
protein expression, which were about 15-fold higher than that
observed for SIVmac239 (Fig. 4). Predominantly, the
truncated form of TM protein and trace amount of full-length
TM were observed in cells infected with SIVmac1A11,
SIVmac2391A11CT, and SIVmac239T, whereas SIV-
mac239 only expressed the full-length form of TM proteinFig. 5. Analysis of proteins of released SIV particles. PBMCs were infected with
(C) or SIVmac1A11 (A, B) and released virus was purified as described in Mater
blotting using a polyclonal SIV antiserum. The amounts of proteins were quantitat
TM(t), truncated TM protein.(Fig. 4). After 28 days of infection in PBMCs, the levels of
protein expression had increased for the chimeric viruses and
were comparable to the parental viruses except for SIVma-
c1A11239Env for which the level was about 35-fold lower
(Fig. 4); this was due to a smaller fraction of infected cells as
observed by surface staining and flow cytometry. The
sequences of SIVmac1A11239CT obtained from PBMCs
over 5 weeks indicated that in one clone, extensive changes in
sequences were observed following amino acid 733, due to
frame shifting at different sites; in seven other clones a site-
specific C to T mutation was present in the env gene which
changed a CAG glutamine codon at position 734 to a TAGSIVmac239 (A), SIVmac2391A11CT (A), SIV23914T (B, C), SIV23918T
ials and methods. The samples were analyzed by SDS-PAGE and Western
ed by densitometer analysis (NIH Image version 1.54). SU, surface protein;
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the SU and TM subunits of the Env protein can affect
replication levels of SIV and that chimeric SIV virus which
contain the 1A11 SU and full-length CT have a replication
deficiency during growth in monkey T cells, but replication-
competent mutant viruses are recovered which possess
truncations in the CT.
Effect of changes in SU subunits on Env incorporation into
SIV particles
We also compared the incorporation into released SIV
virions of Env proteins which contain a full-length or
truncated TM, as well as chimeric Env proteins with differentFig. 6. Neutralization of parental and chimeric SIV viruses by different polyclon
SIVmac239, anti-SIVmac239/17E or anti-SIVsmm9 serum at a dilution of 1:12 b
fixed and stained as described in Materials and methods, and neutralization was m
antibody-treated virus to the number in wells infected with the virus treated withSU subunits. We did not observe a significant difference in
the levels of incorporation of truncated vs. full-length
SIVmac239 Env into virions, as indicated by the Env/Gag
ratio (Fig. 5). However, Env proteins were incorporated at
about a 10-fold higher level into SIVmac1A11 than
SIVmac239 particles. The level of Env incorporation into
SIVmac239 virions was increased considerably in the 18T
mutant with A239T or the 14T mutant with G201S, A239T,
D294N, D374N in the SU subunit of the full-length
SIVmac239 Env, and was comparable with the level of Env
incorporation into SIVmac1A11 particles (Fig. 5). In our
previous electron microscopy studies, SIVmac239 virions
with full-length Env obtained from HUT78 cells contained
less prominent envelope spikes, whereas SIVmac1A11al antisera. SIV was incubated with normal serum, anti-SIVmac251, anti-
efore virus was added to sMAGI cells. At 3 days postinfection, cells were
easured by comparison of the number of blue cells in wells infected with
normal serum. Results are shown with the standard deviation (n = 3).
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and Compans, 2000). We found that levels of processing,
glycosylation, and surface expression of Env proteins were
similar in SIV with parental or mutant Env proteins (not
shown). Taken together, the results demonstrate that
sequence changes in the SU subunit have a significant effect
on the level of Env incorporation into SIV virions.
Membrane fusion activity
We also investigated the effects of the above sequence
differences in the SU andTM subunits on themembrane fusion
activity of the Env proteins. Briefly, HEp2 cells were trans-
fected with plasmids: pCMV239Env(FL), pCMV239Env(T),
pCMV1A11Env and pCMV23914T(T) and at 48 h post-
transfection the cells were detached and used in serial dilutions
to overlay 3T3.T4CCR5 cells. We found similar levels of
syncytia with plasmids that expressed full-length or truncated
Env. These results are consistent with previous studies, which
showed that both SIVmac1A11 Env and SIVmac239 Env
efficiently induced membrane fusion with cells bearing
CCR5CD4, GPR1CD4, GPR15CD4, or STRL33CD4
(Edinger et al., 1998; Marx and Chen, 1998). The results
also indicate that the observed differences in replication are
not related to fusion activity of the envelope proteins.
Sensitivity to neutralization
To evaluate the effects of the sequence differences in SU
and TM on sensitivity to neutralization, we compared
SIVmac1A11 (neutralization-sensitive phenotype), SIV-
mac239 (neutralization-resistant phenotype), and the chi-Fig. 7. Neutralization of mutant SIV viruses with full-length or truncated (T) Env pro
anti-SIVmac251, anti-SIVmac239 or anti-SIVsmm9 serum at a dilution of 1:12 befo
and stained as described in Materials and methods, and neutralization was measurmeric viruses described above using a panel of sera obtained
from monkeys infected with various SIVs (Fig. 6). As
expected, SIVmac1A11 was sensitive and SIVmac239 was
relatively resistant to neutralization by serum antibodies.
SIV1A11239Envwith the SU subunit of SIVmac239 and full-
length CT showed a relatively resistant phenotype like that of
SIVmac239. SIVmac1A11239CT containing the SU subunit
of SIVmac1A11 and full-length 239CTwas neutralized about
80% by anti-SIVmac251 or anti-SIVmac239 antibodies, and
about 10% by anti-SIVmac239/17E or anti-SIVsmm9 anti-
bodies. SIVmac239T was highly resistant to neutralization
with only about 5% neutralization with all antisera tested,
whereas SIVmac239 was neutralized about 35% by anti-
SIVmac251 or anti-SIVmac239 antisera. We found no
changes in the phenotypes of SIV viruses with full-length
or truncated Env after 1 week growth in HUT78, CEMx174,
or rhesus monkey PBMCs (not shown). However, when
SIVmac239 was propagated in cell lines over 2 months, an
increase in neutralization sensitivity was observed as
reported previously (Vzorov and Compans, 2000).
The 14T or 18T mutant SIV viruses with full-length Env
proteins demonstrated significantly higher sensitivity to
neutralization than parental SIVmac239 (not shown) or the
corresponding mutant viruses which possess a truncated
Env proteins (Fig. 7). These results show that the increase in
neutralization sensitivity observed in cell culture-adapted
SIVmac239 is determined by mutations in the SU subunit.
Taken together, these results also indicate that truncation of
Env affects neutralization sensitivity of SIV, but can
increase or decrease neutralization sensitivity depending
upon sequences in the SU subunit. A truncated CT with a
1A11 SU results in increased sensitivity to neutralization; ateins by different polyclonal antisera. SIV was incubated with normal serum,
re virus was added to sMAGI cells. At 3 days postinfection, cells were fixed
ed as in Fig. 6. Results are shown with the standard deviation (n = 3).
Fig. 8. Binding of monoclonal Abs to SIV Env proteins measured by
ELISA. Samples (cell lysates, culture supernatants) were added to
96-well plate coated with monoclonal antibodies and for detection of
protein binding an ELISA assay was used as described in Materials
and methods. Binding of monoclonal Abs KK15, 8C7, 7D3, KK17, KK42,
and VM18S were determined by measuring absorbance (OD) at 450
nm. For each sample, the OD value was calculated by subtracting the
OD obtained with pJW4303-negative control. Upper panel: cell lysates;
lower panel: supernatants. Results are shown with the standard
deviation (n = 3).
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resistance to neutralization; and a truncated CT with an SU
mutation resulting from culture-passage of SIVmac239
results in decrease sensitivity to neutralization.
Binding of anti-SIV Env antibodies
We compared antibody binding to SIV-infected cells to
determine if there was a possible relationship to different
neutralization phenotypes. The binding of polyclonal anti-
bodies to envelope glycoproteins expressed on surfaces of
SIV-infected rhesus PBMCs was measured by using flow
cytometry. The infection was monitored for each viral clone in
parallel samples by RIP analysis and surface biotinylation. In
almost all cases, the relative protein expression by the various
clones was found to be similar to that described above. We
found that the lowest levels of anti-SIVsmm9 or anti-
SIVmac239 antibodies were bound to cells expressing
SIVmac2391A11CT (not shown). The highest levels of
antibodies were bound to cells expressing SIVmac1A11 or
SIVmac239. However, the differences between samples were
not significant. These results indicate that there is no
significant difference in binding of polyclonal antibody to
the viral envelope proteinwhichwould account for differences
in the observed neutralization sensitivity of these viruses.
We further compared the antigenic properties of Env
proteins with full-length and truncated CTs by ELISA using
a panel of monoclonal antibodies. In cell lysates samples,
the SIV gp41 immunodominant epitope (AA591–620) was
efficiently recognized on gp160 from SIVmac239 or gp140
from SIVmac239(T) and SIVmac1A11 plasmids by KK15
mAb (Fig. 8). This mAb bound to gp140 SIVmac239-
14T(T) slightly more strongly than other Env proteins. The
KK17 mAb, which reacted with the SIV Env region (AA8–
303), and KK42 mAb, which reacted with the SIV V3
region (AA321–340), bound efficiently to SIVmac239
gp160, SIVmac239(T) gp140, SIVmac239-14T(T) gp140
and weakly to SIVmac1A11 gp140 constructs. The 8C7
mAb (CD4/CCR5 binding site), 7D3 mAb (CCR5 binding
site), and SIVmac1A11gp130 monoclonal (VM-18S) also
recognized Env of SIVmac239 more efficiently than
SIVmac1A11. In culture supernatants, the monoclonals also
bound more strongly to SIVmac239 gp120 than to
SIVmac1A11 gp120. Only SIVmac1A11 gp130 mAbs
efficiently recognized gp120 from both strains. The results
indicate that the SIVmac239 Env is more efficiently
recognized by most of the mAbs tested despite the greater
resistance of this virus to neutralization, and that Env
truncation did not alter the observed antigenic reactivity of
the Env protein to the mAbs tested.Discussion
In the present study, we demonstrate that differences in
both the SU subunit and the CT of the Env protein of tworelated SIV isolates play important roles in determining viral
growth capacity as well as sensitivity to neutralization by
antibody. SIVmac239 has a long cytoplasmic tail of 164
amino acids, whereas SIVmac1A11 has a truncated CT of
18 amino acids. Our results reveal that the effect of the CT
length on replication shows a striking dependence on the
nature of the SU subunit. A truncated CT in context of the
1A11 SU subunit significantly enhanced replication of
SIVmac1A11 in CEMx174 (a human T-cell line) and rhesus
PBMCs. However, truncation of the Env CT did not have
such an effect on replication kinetics of SIVmac239 in these
cells. We also found that a mutant obtained from a
molecular clone of SIVmac239 which exhibited enhanced
replication in human HUT78 cells, and carried only a single
Fig. 9. Location of mutations in cell culture-passaged SIVmac239Env in the
structure of gp120. The diagram shows gp120 in the same orientation as
Kwong et al. (1998). gp41 is located towards the top and the CD4 binding
site is on the left of the diagram. The location of mutations (orange color)
was determined with multiple alignments from ProDom PD 000124 (1651
protein sequences) A239T in SIVmac239 corresponding to A224 (Protein
Data Bank code 1g9m); D294N to D279, and D374N to K357 of HIV-1
Env (clade B, strain HXBc2). The residue I502 corresponding to I491 is
shown in red. The positions of truncated termini are shown in green.
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replication deficiency in HUT78 cells when a full-length CT
was introduced. A chimeric SIVmac1A11 with a long
SIVmac239 CT also did not replicate in human T-cell lines,
but truncation by acquisition of a stop codon resulted in
replication. The expression level of CD4 on the surfaces of
rhesus monkey PBMCs is several times lower than on CD4-
positive human T lymphocytes (Lewin et al., 1996; Ometto
et al., 1999). A strictly CD4-dependent infection pathway
for SIV including GPR1, GPR15, or STRL33 coreceptors
has been observed in human T-cell lines, whereas a CD4-
independent CCR5 coreceptor entry pathway is observed in
primary rhesus monkey PBMCs (Bannert et al., 2000;
Edinger et al., 1998; Marx and Chen, 1998). There is also
evidence that truncation of the CT results in a more stable
Env structure than is found in proteins with the full-length
TM protein (Allan et al., 1992; Spies et al., 1994). Taken
together, these observations suggest that an altered structure
of the ectodomain in the truncated Env proteins may affect
binding to receptors and/or coreceptors, and therefore affect
infectivity of the viruses.
We observed that the sequence of the SU subunit is
altered during prolonged growth of SIVmac239 in cell
culture, which is correlated with other observations (Means
et al., 1997; Sawyer et al., 1994) with most mutations
located between the V2 and V3 loops. Viruses with the
resulting sequence and a full-length Env protein were
found to be more sensitive to neutralization by antibodies
than the corresponding virus with a truncated Env CT.
However, the mutations observed in the Env of cell
culture-passaged SIVmac239 do not correspond to the
sequence differences between SIVmac239 and SIV-
mac1A11. The higher neutralization sensitivity of both
the cell culture-adapted SIVmac239 and SIVmac1A11
could be due to differences in the exposure of epitopes
which are conformation-dependent.
We analyzed the location of mutations in the cell line-
adapted SIV Env protein based on homology to HIV gp120
(Kwong et al., 1998). By sequence alignment, we found that
the A239T mutation was at a turn region at the edge of
gp120, which points toward the interface with gp41. This
residue may interact with I502, as seen for the correspond-
ing residues in the HIV sequence, and can have strong effect
on this structurally conserved region of the protein. The
D294N mutation had direct interaction with CD4 binding
site, and mutation D374N was located next to CD4 binding
site (Fig. 9). Moreover, by performing multiple alignments
with separation of ungapped regions into blocks we found
that the most frequent mutation A239T (60% of clones)
occurred in one of these blocks. The residue 239 was
observed to be alanine, cysteine, valine, or methionine in
90% of sequences, with the predominant residues being
alanine or cysteine. Threonine was not found in this position
among of HIV and SIV isolates. The observed mutations
were not in common motifs such as leucine zippers, N-
myristoylation, amidation, or predicted motifs which mightinteract with signaling proteins. The mutation G201S had
the effect of addition of a new N-glycosylation site, but this
mutation was found in only a single clone. Taken together,
the results indicate that the observed mutations in cell
culture-adapted viruses do not interfere with known
functions of Env protein, but their location suggests effects
on interaction of gp120 with gp41 or CD4. Truncation in the
cytoplasmic domain could further modulate these critical
changes in the structure of the SU subunit.
The present results also clearly show that truncation of
the Env CT dramatically affects the sensitivity of SIV to
neutralization, and that this effect is dependent on the type
of SU subunit present in the Env protein. The SIV
phenotypes which are most sensitive to neutralization
include viruses which contain the SU subunit of the
SIVmac1A11Env protein and a truncated CT, or SU-14T
mutant viruses of SIVmac239 which contain a full-length
CT. Viruses with the wild-type SIVmac239 Env are
resistant to neutralization, and this resistance is further
enhanced by CT truncation. Taken together, these results
indicate that truncation of the Env CT has a profound
effect on enhancing the differences in neutralization
sensitivity: CT truncation with a sensitive phenotype
(SIVmac1A11) resulted in increased sensitivity to neutral-
ization but CT truncation in the context of a resistant
phenotype (SIVmac239) resulted in higher resistance to
neutralization. Neutralization sensitivity was apparently not
related to differences in the level of binding of polyclonal
A.N. Vzorov et al. / Virology 332 (2005) 89–101 97antibodies to the Env protein or the level of incorporation
of the Env proteins into virions. Env proteins with full-
length or truncated CT also displayed similar fusogenic
activity with cells bearing CD4R5 receptors, as previously
reported (Edinger et al., 1998; Marx and Chen, 1998). In a
previous study, we found that antibodies against HLA
classes I and II were able to neutralize SIVmac239
infectivity. Incorporation of influenza virus HA molecules
into phenotypically mixed SIV virions, furthermore,
renders the virions highly susceptible to neutralization by
antibodies against influenza HA (Vzorov and Compans,
2000). These observations indicate that structural features
of the viral surface proteins are the primary determinant of
neutralization sensitivity of SIV. It is therefore likely that
structural changes in the external domain, which are
induced by changing the length of the CT are important
for both neutralization sensitivity and replication capacity
of SIV.Materials and methods
Cell lines
The recombinant monkey cell line sMAGI, human T-cell
line HUT78, T-B hybrid cell line CEMx174, and mouse
3T3.T4.CCR5 cells were obtained from the American Type
Culture Collection (Manassas, VA). The human 239T cell
line was kindly provided by S. L. Lydy. Rhesus monkey
PBMCs were separated by centrifugation of whole blood
over LSM Lymphocyte Separation Medium (ICN Biomed-
icals Inc., Costa Mesa, CA). Cells were then stimulated with
concanavalin A (Con A, 5 Ag/ml in RPMI 1640 containing
10% heat-inactivated fetal calf serum; interleukin-2, human
(hIL-2), 10 U/ml; 10 mM HEPES; and antibiotics) for 2
days before coculture with 239T cells or virus infection.
SMAGI, 239T and 3T3.T4.CCR5 cells were maintained in
Dulbecco’s minimal essential medium (DMEM) supple-
mented with 10% fetal calf serum and antibiotics. HUT78
and CEMx174 cells were maintained in RPMI 1640
supplemented with 10% fetal calf serum and 10 mM
HEPES; and antibiotics.
Monoclonal antibodies, antisera, and plasma samples
SIV-specific plasma samples from rhesus monkeys
infected with SIVmac239, SIVmac239/17E, or SIVsmm9
were kindly provided by S. O’Neil and H. McClure; sera
from monkeys infected with SIVmac251 were provided by
P. Marx. Monoclonal antibodies against SIVmac251 gp41
(KK15), gp160/gp120 (KK42), gp160/gp120 (KK17), and
SIVmac1A11 gp130 (VM-18S) were provided by the
NIAID AIDS Research and Reference Reagent Program;
antibodies against the SIV CP-MAC (closely related to
SIVmac1A11) CD4/CCR5 binding site (8C7), and CCR5
binding site (7D3) were provided by B. Puffer and R. Doms.Plasmid construction
For construction of chimeric viruses, plasmids
p239SpSp5V, p239SpE3V, and pSIVmac1A11 were provided
by the AIDS Research and Reference Reagent Program,
Division of AIDS (NIH). Plasmid p239spE3V/TMstop carries
a mutation which creates a stop codon after AA733 of the
Env SIVmac239 and was provided by T. Kodama. Vector
pSP72 was obtained from Promega Corporation (Madison,
WI). All plasmid constructs were made in the vector
pSP72DBglII obtained by digestion with BglII and repaired
with Klenow polymerase. For recovery of infectious
SIVmac239 or SIVmac1A11 virions, we prepared two pairs
of plasmid constructs for each virus which contained
portions of molecularly cloned SIVmac239 or SIVmac1A11.
A similar strategy to clone and obtain infectious viruses was
used by York-Higgins et al. (1990) and Banapour et al.
(1991). One plasmid of SIVmac239 is designated p239 5V
and represents a construct which spans the HindIII site
upstream of the 5VLTR in cellular DNA flanking the unique
ClaI site in the SIVmac239 env gene. The second is
designated p239 3Vand spans the ClaI site to the EcoRI site
in the 3Vcellular flanker DNA. Identical restriction sites were
used to obtain SIVmac1A11 plasmids, except that an SphI
site in the 5Vcellular flanking DNA was utilized. The two
1A11 plasmids were designated p1A11 5Vand p1A11 3V. We
used NheI and BglII restriction sites in parental 3Vplasmids to
obtain plasmids for chimeric viruses SIVmac2391A11CT
and SIVmac1A11239CT with reciprocal exchange of CT,
which were designated p3V1A11239CT and p3V2391A11CT.
p1A11239SU5V was constructed by replacement of the
SIVmac1A11 SU Env sequence domain by SIVmac239
Env SU by using restriction sites SphI and ClaI.
The plasmids pCMV1A11SU239(T), pCMV23914T(T)
and pCMV1A11Env were constructed by cloning the
SIVmac1A11 env sequence or SIVmac239 env mutant
(clone 14T) into the pJW4303 expression vector in frame
with a tissue plasminogen activator leader (Vzorov et al.,
1999). The SIVmac1A11 env SU subunit sequence was
amplified by PCR with pSIVmac1A11 template and two
primers described before (Vzorov et al., 1999). The PCR
fragment was inserted into the XbaI to ClaI site of p239-
RE(t)DClaI. An XbaI to BamHI restriction fragment of this
plasmid was ligated into pJW4303 in the NheI to BamHI
site. The plasmid containing the SU subunit of SIV-
mac1A11 and the TM subunit of SIVmac239 with the CT
truncation was designated pCMV1A11SU239T. The plas-
mid pCMV1A11Env containing the entire 1A11 env coding
sequence was obtained by exchange of ClaI to BamHI
restriction fragment from pSIVmac1A11 to pCMV1A11-
SU239T. The HindIII to ClaI fragment of the p5V23914T
(described below) was cloned into the same site of p239-
RE(t)DClaI and then an XbaI to BamHI restriction fragment
of this plasmid was ligated into pJW4303 in the NheI to
BamHI site. The plasmid with mutations in the 239 SU
subunit (see above) and a truncated Env was designated
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pCMV239Env(T) containing the SIV239 env coding
sequence without or with a stop codon (AA734stop),
respectively, were described before (Vzorov et al., 1999).
Transfection and virus infection
To avoid mutations that may occur during prolonged
growth of SIV, we used a two-step method to obtain SIV
virus stocks. First, viruses were generated in transiently
transfected 239T cells by intracellular ligation and secondly,
the virus produced by single-cycle replication in 239T cells
was used to infect human CEMx174, HUT78, or rhesus
monkey PBMCs.
To recover infectious SIV, plasmids were digested with
ClaI to generate linear molecules and 10 Ag of DNA,
representing equimolar amounts of each of the two
plasmids, was transfected into 239T cells using calcium
phosphate precipitation (Bartz and Vodicka, 1997). For
short-term infection of suspension cells (7 days), we used
the supernatants from transfected 239T cells collected after
72 h. We used four methods to quantitate virus yields
obtained after transfection of 239T cells and normalize input
virus inocula for subsequent infection. The ratio of gp120 to
p27 was examined by SDS-PAGE and an ECL (enhanced
chemiluminescence) kit (Amersham Life Science, Piscat-
away, NJ) and the amount of protein was quantitated by
using densitometer analysis (NIH-Image v. 1.54); the p27
content was determined by SIV Core Antigen Assay
(Coulter Corporation, Miami, FL); and infectious units
were determined by colorimetric reverse transcriptase assay
(Roche, Indianapolis, IN) RT- and sMAGI (Chackerian et
al., 1995) assays. For most virus stocks, the results of these
assays were similar (Table 1). For 7-day infection, we used
SIV at a multiplicity of infection (MOI) of 0.001, which
was equal to approximately 300 ng of p27 or 1.5 ng of RT
per 5  106 cells. SIV was inoculated with DEAE-dextran
at a final concentration of 15 Ag/ml; after 2 h, cells were
washed once and complete RPMI 1640 was added.
For long-term infection, DMEM was removed at 48 h
post-transfection, and the cells were washed once in
RPMI 1640. Then, 5  106 suspension cells were added
to 100 mm plates in 5 ml of RPMI 1640 growth medium.Table 1
Virus stock standardization
Virus SMAGI titera
IUb/ml
ELISA (p27)a
ng/ml
IU/ng
SIV239 1  104 300 33
SIV2391A11CT 1  104 300 33
SIV1A11 5  103 225 22
SIV1A11239CT 2  102 325 0.6
SIV1A11239Env 2  102 230 0.9
SIV23914T 8  103 340 24
SIV23918T 1  104 360 28
a Assays are described in Materials and methods.
b Infectious units.Coculture was continued overnight. The following day,
suspension cells were removed from virus-transfected cells
and placed in individual T-25 flasks. These cultures were
maintained for 21 days, cells were split 1:3 and fresh
medium and 3  106 cells per T-75 flask were added to
infected cells on days 7 and 14. Infected cells (during 7 or
21 days infection) were regularly monitored for cytopathic
effects and culture supernatants were assayed for RT
activity by colorimetric reverse transcriptase assay (Roche),
for production of Gag antigen by SIV Core Antigen Assay
(Coulter Corporation), or for infectivity by sMAGI assay
(Chackerian et al., 1995).
PCR sequencing of cell culture-passage SIV and
construction of mutant viruses
SIVDNAwas extracted from infectedHUT78 cells using a
commercial DNeasy Tissue kit (Qiagen) and then the env gene
sequence was amplified by PCR. The sense primer used was
5VATGGGATGTCTTGGGAATCAGCTGC, corresponding
to nucleotides (nt) 6604 to 6628 in the SIVmac239 sequence
(accession number M33262). The sequence of the antisense
primer was 5VACAAGAGAGTGAGCTCAAGCCCTTGTC,
corresponding to nt 9215 to 9241. PCR amplification was
carried out by using Taq DNA polymerase (Roche) and 30
cycles with steps of 1 min 94 8C, 2 min at 62 8C, and 3
min 72 8C with 10 min extension at 72 8C. The PCR
fragments were inserted into the pCR4-TOPO (TA-cloning
kit, Invitrogen, San Diego, CA). Then, plasmid DNA was
used to transform competent cells under ampicillin
selection. Finally, single colonies of cells were obtained
and used to prepare DNA for sequencing. The nucleotide
sequences of the cloned viruses were determined by the
dideoxy method at the Emory DNA Sequencing Core
Facility.
For construction of viruses with mutations we used
pCR4-TOPO plasmids with inserted nucleotide sequences
of the cloned viruses which contained the desired muta-
tion(s). The env gene fragment with SphI and ClaI sites
from p5V239 was inserted in pSP72 with a deleted HindIII
restriction site. The fragment with HindIII and ClaI sites
from this plasmid was exchanged with the fragment of the
pCR4-TOPO plasmid. Then, the mutant env gene fragment
was released by digestion with SphI and ClaI, and used to
insert back into p5V239. The env genes of all mutants were
subjected to DNA sequence analysis to confirm that the
desired mutations were achieved.
Protein sequence analysis
For sequence alignments and analysis of protein motifs
the SIVmac239 Env (Genebank database M33262)
(AAA47637.1, Q88018_SIVCZ) sequence was analyzed
by the following: NCBI BlastP (http://www.ncbi.nlm.nih.
gov/BLAST/); ProDom (http://protein.toulouse.inra.fr/
prodom/current/html/form.php) (Corpet et al., 2000); Pfam
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www.ebi.ac.uk/interpro); Blocks (http://blocks.fhcrc.org/);
Logos visualization, Prosite (http://us.expasy.org); Prints
(http://bioinf.man.ac.uk/dbbrowser/PRINTS/); Motif (http://
motif.genome.jp); PredictProtein (http://www.embl-
heidelberg.de/predictprotein/predictprotein.html; and Coils
(ISREC-server). To visualize HIVgp120 (Kwong et al.,
1998) and interpret the positions of SIVmac mutations
based on alignment, we used RasMac 2.6-UCB program.
Computer packages were obtained from BIMCORE
(Molecular Graphics), Emory University or online (see
above).
Purification of virus particles
The culture medium from SIV-infected cell cultures was
harvested, clarified by centrifugation at 3500 rpm for 20 min
(GS-15R Beckman), and then filtered through a 0.45-Am-
pore size filter (Nalge, Rochester, NY). Aliquots from each
sample were analyzed by SIV Core Antigen Assay (Coulter
Corporation) and the volume of the samples used for the
next step was adjusted by addition of medium to equalize
the amount of p27 antigen. Then the samples were spun by
centrifugation for 2 h at 24,000 in an SW55 tube and pellets
were used for Western blot analysis.
Western blotting
For Western blotting, proteins of purified virus particles
were separated on a 10% polyacrylamide gel and transferred
to a nitrocellulose filter (Bio-Rad, Hercules, CA). Filters
were blocked for 16 h at 4 8C with 5% nonfat dry milk and
10% bovine serum (HyClone, Logan, UT) in PBS and
incubated with an SIV-specific antiserum from an infected
rhesus monkey. After three washes with PBS-Tween 20
(0.05%), the filters were incubated with an anti-monkey
immunoglobulin G (IgG)-peroxidase conjugate (Sigma, St.
Louis, MO) in PBS-Tween 20-milk. After three washes,
bound peroxidase activity was revealed using an enhanced
chemiluminescence (ECL) kit (Amersham Life Science
Piscataway, NJ).
Radioimmunoprecipitation (RIP) analysis and cell surface
biotinylation
For RIP analysis, SIV-infected cells were radiolabeled
with 50 ACi of [35S] cysteine/methionine per ml for 4 h. The
procedure for biotinylation of cell surface proteins used was
similar to that described by Altin and Pagler (1995). At the
end of the labeling period, the cells were washed three times
with ice-cold PBS and incubated with 1 ml of 0.5 mg/ml
solution of sulfo-NHS-SS-Biotin (Pierce) at room temper-
ature for 30 min. The cells were then washed three times
with ice-cold PBS and lysed in RIP buffer (Vzorov and
Compans, 2000). The samples were immunoprecipitated for
16 h with SIVmac251-specific antisera from an infectedrhesus monkey and protein A-agarose. The agarose beads
were then washed three times and divided into two equal
aliquots. One aliquot was boiled in 10% SDS for 5 min,
diluted with lysis buffer, and incubated with streptavidin-
agarose (Pierce, Rockford, IL) for 4 h at 4 8C. The beads
were washed three times, and proteins were characterized by
SDS-10% polyacrylamide gel electrophoresis (PAGE) and
autoradiography.
Flow cytometry and FACS analysis
The binding of polyclonal anti-SIV antibodies to proteins
on surfaces of SIV-infected cells was analyzed by flow
cytometry. Rhesus monkey PBMCs infected with SIV were
harvested 5 days after infection and 5  105 cells were used
for staining with anti-SIVmac239 antibodies. The cells were
resuspended and incubated in 100 Al of FACS buffer
(DPBS, 1% FCS; 0.09% sodium azide) with appropriately
diluted antibodies for 60 min or overnight at 4 8C. Then,
cells were washed three times with FACS buffer and
incubated with secondary anti-monkey IgG-FITC conjugate
(Sigma) for 30 min at 4 8C. After three washes in FACS
buffer, the samples were analyzed by a FACSCaliber (Becton
Dickinson, San Jose, CA). The data were analyzed using
FlowJo v 3.4 software (Tree Star, Inc., San Carlos, CA).
Neutralization assays
Neutralization assays were performed on sMAGI cells as
described previously (Vzorov and Compans, 2000).
Cell fusion assay
Hep-2 cells were transfected by the calcium phosphate
precipitation method with CMV plasmids described above.
After 48 h cells were collected and counted, diluted, and
aliquots containing from 5  101 to 2.5  103 cells were
then added to 3T3.T4CCR5 cell monolayers in 96-well
plates. After 5 or 20 h of cocultivation, the samples were
fixed, stained with crystal violet and the level of cell fusion
was evaluated by microscopic observation.
ELISA
To determine binding of monoclonal antibodies to Env
proteins, we used a modified version of the procedure
described by Moore et al. (1994). Briefly, 96-well microtiter
plates were coated with 2–5 Ag/ml of monoclonal antibodies
in carbonate-bicarbonate buffer at pH 9.6 overnight at 4 8C.
Plates were washed three times with PBS containing 0.05%
Tween 20. In order to reduce the background, the plates
were blocked with 3% bovine serum albumin (BSA)
(Sigma) prepared in PBS for 1 h at 37 8C. Plates were
washed again as described above. The samples (see below)
were diluted 1:5 or 1:20 in medium with 10% FBS, added to
the plate, and incubated overnight at room temperature.
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Tween 20. The captured envelope proteins were probed with
polyclonal SIVmac251-specific antisera from an infected
rhesus macaque diluted in PBS with 3% BSA, 10% FBS,
0.05% Tween 20. After 1 h incubation and five washes,
plates were incubated with an anti-monkey IgG peroxidase
conjugate (Sigma) in PBS with 3% BSA, 10% FBS, 0.05%
Tween 20. After washing, plates were developed with
tetramethylbenzidine (TMB). We then determined absorb-
ance (OD) at 450 nm. For each sample, the OD value was
calculated by subtracting the value obtained with pJW4303
as a negative control.
Protein expression was monitored for each Env construct
by RIP analysis and surface biotinylation. To prepare
samples for ELISA, at 48 h 239T cells transfected with
CMV plasmids were washed three times, detached by PBS-
EDTA, counted and 4  105 cells were lysed using 0.5%
nonidet P40 in Tris-buffered saline [25 mM Tris–HCl (pH
7.5), 150 mM NaCl]. The cell lysates were centrifuged at
14,000 rpm for 30 min and the supernatants (cell lysates)
were collected and frozen at 80 8C until use. The culture
supernatants from these cells were precleared, collected, and
also frozen at 80 8C.Acknowledgments
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